We are in pursuit of identifying and developing life-saving solutions for global healthcare problems with a focus on cancer diagnostics and cure.
Innovating with Intent
Our mission, vision, and purpose reflect our commitment to meaningful progress and measurable outcomes.
Mission
To develop innovative methodologies to develop diagnostic tests that provide early indicators of oncogenesis and enable informed treatment strategies.
Vision
To collectively advance and improve human health by developing biomedical innovations into practical applications that have wider reach, accessibility and affordability.
Purpose
To positively impact everyone, by developing solutions that have reduced time to decision making and providing precise information for a chosen course of action.
What We Stand For
Our values define our commitment to rigorous science, responsibility, and meaningful impact.
Work on challenges with cutting-edge science and innovation.
Work towards making it accessible and affordable to the masses.
Ensure critical clinical validations for every outcome.
Bio-materials with high specificity, efficiency and sensitivity.
Scientific disciplines with interdisciplinary intelligence at the core.
Take every little step to ensure cancer patient’s lives are saved.
Detect cancer relapse early, when it can be cured. We are committed to bringing stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
Rigour in every action.
Every product undergoes intense design and development.
Leaving no stone unturned.
We follow the most stringent quality norms like ISO13485 and NABL regulatory requirements.
Passionate and emphatic.
We are committed to developing solutions for unmet medical needs.
We build high-risk innovative products, which have a very long life-cycle, using novel biomaterials.
With collaboration with knowledge leaders
Licences
License No:
MFG / IVD2019 / 000004
License Name:
MD 29 – Permission to import or manufacture new in-vitro diagnostic medical device.
Licensing Authority:
Central Drug Standards Control Organisation (CDSCO), New Delhi, India.
License No:
MFG / IVD2019 / 000031
License Name:
MD 9 – License to Manufacture for Sale or for Distribution of Class C or Class D medical device.
Licensing Authority:
Central Drug Standards Control Organisation (CDSCO), New Delhi, India.
ISO 13485:2016 Certified
NABL Accredited Laboratory
Early detection is half the battle won.
Book a Test
Simply book a Test online or over a phone call and schedule a visit by our registered phlebotomists.
Sample Collection
Upon booking the Test, one of our registered phlebotomists shall visit and collect 10 ml of patient’s blood sample.
Receive Report
A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.